Alle Storys
Folgen
Keine Story von LifeWatch AG mehr verpassen.

LifeWatch AG

EANS-Adhoc: LifeWatch AG to report on Fourth Quarter 2010 and Full Fiscal Year 2010 Results on March 1, 2011 + Press release and Letter to Shareholders at 7:00 a.m. CET (01:00 EST); + Analyst and media conference held in Zurich at 10:00 a.m. CET; ...

2 Dokumente

  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
Company Information/LifeWatch AG
09.02.2011
Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss 
Exchange: LIFE) will report on its results for the fourth quarter 
2010 and full fiscal year 2010 on Tuesday, March 1, 2011 in Zurich.
A PDF-version of the invitation and a registration form can be found 
at the end of this message.
Press Release and Letter to Shareholders at 7:00 a.m. CET (01:00 a.m.
EST):
LifeWatch will publish internationally the results for the fourth 
quarter 2010 and full fiscal year 2010 in a press release and letter 
to shareholders at 7:00 a.m. CET.
Analyst and media conference at 10:00 a.m. CET:
LifeWatch will report on the fourth quarter 2010 and full fiscal year
2010 results at an English-speaking analyst and media conference will
take place in Zurich on:
Tuesday, March 1, 2011; 10:00 a.m. CET, at the Zunfthaus zur Saffran,
Limmatquai 54, 8001 Zurich/Switzerland
Please confirm your participation at the analyst and media conference
by returning the registration form by February 24, 2011.
International Live Conference Call/Web cast at 10:00 a.m. CET:
For international participants, a combined conference call and audio 
web cast, accompanied by presentation visuals, is broadcast online at
10:00 a.m. CET (04.00 a.m. EST) live from the conference in Zurich. 
Further information regarding the audio web cast and respective 
technical requirements can be found in the Investor Relations section
of the LifeWatch Website www.irlifewatch.com in due time. An archived
version of the web cast will remain available for viewing.
The local dial-in numbers for the conference call are as follows:
  • 41 (0)91 610 56 00 (Europe);
  • 44 (0)203 059 58 62 (UK);
  • 1 (1)866 291 41 66 (USA - Toll-free);
All participants are requested to dial in at least ten minutes prior 
to the call. No PIN is required to access the call.
About LifeWatch AG:
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on 
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare 
technology and solution company, specializing in advanced telehealth 
systems and wireless remote patient monitoring services. LifeWatch 
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the 
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent 
company of LifeWatch Services Inc., a leading US-based cardiac 
monitoring service provider, and manufacturer of telecardiology 
products. LifeWatch is also introducing a new program for Home 
SleepTesting of Obstructive Sleep Apnea (OSA) patients under the 
brand name NiteWatch. For additional information, please visit 
www.lifewatch.com.
Sign-up for customized E-mail alerts and documentation requests is 
available at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All 
statements other than statements of historical facts contained in 
this press release, including statements regarding future results of 
operations and financial position, business strategy and plans and 
objectives for future operations, are forward- looking statements. 
The words "believe," "may," "will," "estimate," "continue," 
"anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these 
forward- looking statements largely on current expectations and 
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business 
strategy, short term and long term business operations and 
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking 
events and circumstances described may not occur and actual results 
could differ materially and adversely from those anticipated or 
implied in the forward- looking statements. All forward-looking 
statements are based only on data available to LifeWatch AG at the 
time of the issue of this press release. LifeWatch AG does not 
undertake any obligation to update any forward-looking statements 
contained in this press release as a result of new information, 
future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF 
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR 
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES.  THIS 
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN 
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH 
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE 
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN 
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE 
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. 
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.  ANY 
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG 
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED 
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL 
STATEMENTS OF THE ISSUER.
Attachments with Announcement:
http://resources.euroadhoc.com/us/1NGpmsum
http://resources.euroadhoc.com/us/SvfM1szk
end of announcement                               euro adhoc

Contact:

Sensus Investor and Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard

Weitere Storys: LifeWatch AG
Weitere Storys: LifeWatch AG